AR092957A1 - Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion - Google Patents

Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion

Info

Publication number
AR092957A1
AR092957A1 ARP130103663A ARP130103663A AR092957A1 AR 092957 A1 AR092957 A1 AR 092957A1 AR P130103663 A ARP130103663 A AR P130103663A AR P130103663 A ARP130103663 A AR P130103663A AR 092957 A1 AR092957 A1 AR 092957A1
Authority
AR
Argentina
Prior art keywords
speed
calcium carbonate
deintegration
formulation
manufacturing
Prior art date
Application number
ARP130103663A
Other languages
English (en)
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR092957(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of AR092957A1 publication Critical patent/AR092957A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/006—Pressing and sintering powders, granules or fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/772—Articles characterised by their shape and not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Geology (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Una forma farmacéutica de desintegración veloz oral que comprende carbonato de calcio natural o sintético funcionalizado, por lo menos un ingrediente activo y por lo menos un desintegrante, donde dicho carbonato de calcio natural o sintético funcionalizado es un producto de la reacción de carbonato de calcio natural o sintético con dióxido de carbono y uno o más ácidos, donde el dióxido de carbono se forma in situ mediante el tratamiento ácido, y/o es suministrado desde una fuente externa, y donde el comprimido se disuelve en menos de 20 segundos cuando se introduce en un entorno acuoso.
ARP130103663A 2012-10-12 2013-10-09 Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion AR092957A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12188344.1A EP2719373B1 (en) 2012-10-12 2012-10-12 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US201261713671P 2012-10-15 2012-10-15

Publications (1)

Publication Number Publication Date
AR092957A1 true AR092957A1 (es) 2015-05-06

Family

ID=47022552

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103663A AR092957A1 (es) 2012-10-12 2013-10-09 Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion

Country Status (27)

Country Link
US (1) US20150283082A1 (es)
EP (2) EP2719373B1 (es)
JP (1) JP6196676B2 (es)
KR (1) KR101740835B1 (es)
CN (2) CN104768531A (es)
AR (1) AR092957A1 (es)
AU (1) AU2013328639B2 (es)
BR (1) BR112015008139B1 (es)
CA (1) CA2884912C (es)
CL (1) CL2015000893A1 (es)
CO (1) CO7350657A2 (es)
DK (2) DK2719373T3 (es)
ES (2) ES2628371T3 (es)
HR (1) HRP20191082T1 (es)
HU (1) HUE044281T2 (es)
IL (1) IL237766B (es)
MX (1) MX369779B (es)
MY (1) MY174635A (es)
PL (2) PL2719373T3 (es)
PT (1) PT2916816T (es)
RU (2) RU2018127317A (es)
SG (1) SG11201502290SA (es)
SI (2) SI2719373T1 (es)
TR (1) TR201909173T4 (es)
TW (1) TWI583387B (es)
UY (1) UY35071A (es)
WO (1) WO2014057038A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2654577T5 (es) 2013-12-13 2021-06-17 Omya Int Ag Composición limpiadora abrasiva
CA2937049C (en) 2013-12-16 2024-01-16 The University Of British Columbia Self-fueled particles for propulsion through flowing aqueous fluids
EP2921173A1 (en) 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
EP2949708B1 (en) 2014-05-30 2018-04-04 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
TWI565763B (zh) 2014-05-30 2017-01-11 歐米亞國際公司 製造包含表面經反應碳酸鈣之顆粒的方法
EP2957603A1 (en) 2014-06-20 2015-12-23 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275946A1 (en) * 2016-07-25 2018-01-31 Omya International AG Post treatment of surface-reacted calcium carbonate with different functional cations
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3594289A1 (en) * 2018-07-13 2020-01-15 Omya International AG Surface-reacted calcium carbonate for stabilizing mint oil
CN118593436A (zh) * 2018-09-17 2024-09-06 Omya国际股份公司 包含共加工的微晶纤维素和经表面反应碳酸钙的高性能赋形剂
EP3682901A1 (en) 2019-01-21 2020-07-22 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP3622966A1 (en) 2018-09-17 2020-03-18 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
CN109749745A (zh) * 2018-12-21 2019-05-14 西北农林科技大学 一种利用土体固化溶液加固土体的方法
US11113797B1 (en) 2019-08-19 2021-09-07 Snap Inc. Passive flash imaging
WO2021219529A1 (en) 2020-04-28 2021-11-04 Omya International Ag Method for the production of free-flowing granules
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
CN115551982A (zh) * 2020-05-28 2022-12-30 联合利华知识产权控股有限公司 片剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
US4650699A (en) * 1983-04-18 1987-03-17 Sermetel Thixotropic alumina coating compositions, parts and methods
US6066337A (en) 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5635210A (en) 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
US20050244493A1 (en) * 2004-04-30 2005-11-03 Withiam Michael C Rapidly disintegrating tablets comprising calcium carbonate
DK2070991T3 (da) 2007-12-12 2010-12-20 Omya Development Ag Fremgangsmåde til frembringelse af overflademodificeret, udfældet calciumcarbonat
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
US8303868B2 (en) * 2009-01-26 2012-11-06 Shin-Etsu Chemical Co., Ltd. Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
JP4562797B1 (ja) * 2009-05-29 2010-10-13 マイラン製薬株式会社 沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
PL2264108T3 (pl) 2009-06-15 2012-07-31 Omya Int Ag Sposób wytwarzania przereagowanego powierzchniowo węglanu wapnia, z wykorzystaniem słabego kwasu
PT2377900E (pt) * 2010-04-16 2013-11-07 Omya Int Ag Processo para preparar um material mineral com superfície modificada seus produtos resultantes e suas utilizações

Also Published As

Publication number Publication date
RU2018127317A3 (es) 2022-03-24
HUE044281T2 (hu) 2019-10-28
DK2719373T3 (en) 2017-07-03
PL2916816T3 (pl) 2019-09-30
MX2015004234A (es) 2015-06-10
DK2916816T3 (da) 2019-07-01
TW201438722A (zh) 2014-10-16
EP2916816A1 (en) 2015-09-16
CN104768531A (zh) 2015-07-08
EP2719373A1 (en) 2014-04-16
KR20150063444A (ko) 2015-06-09
CL2015000893A1 (es) 2015-08-28
IL237766A0 (en) 2015-05-31
SG11201502290SA (en) 2015-04-29
PL2719373T3 (pl) 2017-10-31
US20150283082A1 (en) 2015-10-08
RU2676087C2 (ru) 2018-12-26
BR112015008139A2 (pt) 2017-07-04
AU2013328639A8 (en) 2015-05-14
PT2916816T (pt) 2019-06-28
CA2884912A1 (en) 2014-04-17
RU2018127317A (ru) 2019-03-14
TWI583387B (zh) 2017-05-21
ES2732841T3 (es) 2019-11-26
JP2015533140A (ja) 2015-11-19
AU2013328639A1 (en) 2015-04-02
RU2015115916A (ru) 2016-11-27
BR112015008139B1 (pt) 2022-06-07
CA2884912C (en) 2018-01-02
JP6196676B2 (ja) 2017-09-13
IL237766B (en) 2021-07-29
ES2628371T3 (es) 2017-08-02
WO2014057038A1 (en) 2014-04-17
HRP20191082T1 (hr) 2019-10-18
AU2013328639B2 (en) 2016-09-15
EP2916816B1 (en) 2019-03-27
EP2719373B1 (en) 2017-04-19
TR201909173T4 (tr) 2019-07-22
SI2719373T1 (sl) 2017-07-31
SI2916816T1 (sl) 2019-08-30
MX369779B (es) 2019-11-21
UY35071A (es) 2014-05-30
MY174635A (en) 2020-05-04
CO7350657A2 (es) 2015-08-10
CN110742867A (zh) 2020-02-04
KR101740835B1 (ko) 2017-05-26

Similar Documents

Publication Publication Date Title
AR092957A1 (es) Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion
UY35070A (es) ?Sistemas de administración y formulación de fármacos de retención gástrica, y método para su preparación usando carbonato de calcio funcionalizado?.
UY36313A (es) Composición que comprende un carbonato de calcio reaccionado en la superficie como agente antiaglomerante, y método para producirla
ES2553091T3 (es) Nuevos portadores recubiertos de agentes activos de liberación controlada
CL2015002145A1 (es) Preparación, usos y formas sólidas de ácido obeticólico (divisional de solicitud n° 3475-2014)
BR112014004460A2 (pt) material polimérico para um recipiente isolado
MX2016014438A (es) Productos de consumo.
MX2016014529A (es) Metodos para formar licor de tratamiento acuoso.
MX2017008937A (es) Carbonato de calcio tratado en la superficie con estabilidad mejorada en ambientes con un ph de 4.5 a 7.
PE20140255A1 (es) Tableta dispersable en forma oral
BR112015009329A2 (pt) material polimérico para um recipiente isolado
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
CL2012003729A1 (es) Composicion farmaceutica oral que comprende monohidrato de monolactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, uno o mas rellenos, un desintegrante y un lubricante; proceso de preparacion de la composicion.
EA201171399A1 (ru) Способ и композиция для улучшения всасывания лекарственных средств
MY191875A (en) Solid dosage form
BR112014030680A2 (pt) forma de dosagem efervescente
AR076576A1 (es) Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos
MY186332A (en) Pentosidine production inhibitor
MX2012007393A (es) Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.
CL2020001926A1 (es) Uso de carbonato de calcio funcionalizado como ingrediente activo.
MX2016014261A (es) Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis.
BR112015014739A2 (pt) carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
WO2015074667A3 (en) Composition for dermatitis
WO2013127539A3 (de) Pharmazeutische formulierung enthaltend flupirtin
WO2013136346A3 (en) Taste masking pharmaceutical orally dissolving strips of lornoxicam

Legal Events

Date Code Title Description
FC Refusal